BL Pharmtech (XKRX:065170) Other Net Income (Loss) : ₩12,435 Mil (TTM As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is BL Pharmtech Other Net Income (Loss)?

BL Pharmtech's Other Net Income (Loss) for the three months ended in Sep. 2024 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩12,435 Mil.

BL Pharmtech's quarterly Other Net Income (Loss) increased from Mar. 2024 (₩0 Mil) to Jun. 2024 (₩0 Mil) but then declined from Jun. 2024 (₩0 Mil) to Sep. 2024 (₩0 Mil).

BL Pharmtech's annual Other Net Income (Loss) increased from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩787 Mil) and increased from Dec. 2022 (₩787 Mil) to Dec. 2023 (₩13,952 Mil).

BL Pharmtech Other Net Income (Loss) Historical Data

The historical data trend for BL Pharmtech's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BL Pharmtech Other Net Income (Loss) Chart

BL Pharmtech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

787.10

13,951.85

BL Pharmtech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial															1,145.46	12,434.84	-	-	-

BL Pharmtech Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩12,435 Mil.

BL Pharmtech Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of BL Pharmtech's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

BL Pharmtech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » BL Pharmtech Corp (XKRX:065170) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

193-12 Daeyang-ro, Samseong-myeon, Eumseong-gun, Chungbuk, KOR, 138-200

Website

http://www.blpharmtech.com

BL Pharmtech Corp is engaged in the distribution and sale of healthy functional foods.

BL Pharmtech Headlines

No Headlines